If you are an agri-tech biotech firm dealing with crop pathogens — this project developed programmed C. elegans worms that detect, locate and attack invading pathogens. This provides a 100% environmentally-compatible alternative to chemical pesticides.
Genetically Programmed Biological Micro-Robots for Precision Agriculture and Medicine
Imagine tiny living creatures, like worms, that act as organic drones. Instead of metal and wires, their brains are rewritten to follow specific instructions, like hunting pests or delivering medicine. They are completely natural, meaning they biodegrade and don't pollute the environment after their job is done.
What needed solving
Conventional robots lack the dexterity and bio-compatibility to operate inside living bodies or complex soil environments without causing damage or pollution.
What was built
A system of genetically modified C. elegans worms with synthetic gene circuits for aggregation and swarming, and a microfluidic/optogenetic demonstration tool.
Who needs this
Who can put this to work
If you are a medical device manufacturer dealing with invasive surgical procedures — this project developed medicinal nematodes that can enter the body, perform specific medical procedures and then leave. This offers a level of agility and bio-compatibility unattainable by electromechanical robots.
If you are a municipal sanitation service dealing with clogged sewage systems — this project developed the concept of sanitation cockroaches to clear sewage systems. These biological robots are designed to stay out of houses while cleaning pipes.
Quick answers
What is the cost or price of implementing BABots?
Based on available project data, there is no specific pricing or unit cost mentioned; however, the EU contribution for development is EUR 3,251,081.
Can this technology be scaled for industrial use?
The project notes that BABots are self-producible, which suggests a high potential for scaling compared to traditional robot manufacturing.
What is the IP and licensing status?
Based on available project data, specific licensing terms are not listed, but the project is currently in the research and demonstration phase.
How are the safety and regulatory risks managed?
The team is implementing a multi-layered biocontainment apparatus and developing a dedicated safety, ethical and regulatory framework.
What is the timeline for commercial availability?
The project period runs from 2023-10-01 to 2027-09-30, indicating it is currently in the development stage.
Who built it
The consortium consists of 6 partners across 5 countries, showing a strong academic lean with 3 universities and 2 research organizations. With an industry ratio of 17% and only 1 SME involved, the project is currently driven by scientific discovery rather than immediate commercialization, though the inclusion of an industrial partner suggests a path toward application.
Contact UNIVERSITE DE NAMUR in Belgium
Talk to the team behind this work.
Contact us to explore licensing opportunities for bio-robotic control circuits.